What’s on the horizon for nonalcoholic steatohepatitis (NASH) treatment?
The future of NASH treatment is more promising than ever with improved methods for diagnosis and new drugs in development.
Read More
Evernorth Announces Industry-First Financial Guarantee For GLP-1 Spend
EncircleRx solution now includes financial predictability for health plan sponsors to help expand access for appropriate patients.
Read More
Evernorth’s New Behavioral Care Practice Offers Quality Care To Improve Mental Well-Being
Evernorth is launching an outpatient behavioral health practice to expand access to quality, in-network therapy for millions of people.
Read More
What impact will the Inflation Reduction Act have on health plans?
Plan sponsors should be aware of the effects the law will have on Medicare Part D over the coming years.
Read More
Express Scripts kicks off meetings with independent pharmacists to close gaps in care
A new committee, which includes independent pharmacy owners from across the country, will meet regularly to discuss how Express Scripts can and should work to enable an expanded role for pharmacists.
Read More
The future of gene therapy
Recent research suggests that the number of gene therapies on the market is likely to increase to over 60 by 2030. As rapid advancements in the field continue, here is what plan sponsors can expect to...
Read More